Shareholding for the Period Ended March 31, 2017
Fredun Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly Click here17-04-2017
17-04-2017
Outcome of Board Meeting
1) Minutes of Previous Meeting 2) Credit Facility Induslnd Bank 3) Signing authority to Mr Harshad Patil Head PPIC 4) Signing authority to Mrs Amruta Gaonkar Dy Head Regulatory Affairs24-03-2017
Board Meeting on March 24, 2017
Fredun Pharmaceuticals Ltd has informed BSE that a Meeting of the Board of Directors of the Company will be held on the March 24, 2017 to discuss, consider and approve the matter of, obtaining Loan/Credit facility of upto 1 Crore 50 Lakhs from Indusind Bank for a period of 90 days/3 months.20-03-2017
Outcome of Board Meeting
Fredun Pharmaceuticals Ltd has informed BSE about Outcome of Board Meeting held on February 24, 2017.24-02-2017
Board Meeting on Feb 24, 2017
Fredun Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 24, 2017, to discuss, consider and approve the matter of the Increasing Authorised Capital of the Company.17-02-2017
Standalone Financial Results, Limited Review Report for December 31, 2016
Fredun Pharmaceuticals Ltd has informed BSE about : 1. Standalone Financial Results for the period ended December 31, 20162. Standalone Limited Review for the period ended December 31, 201613-02-2017
Outcome of Board Meeting
Fredun Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 13, 2017, commenced at 1.10 p.m and concluded at 4.00 p.m. as under:- Loan amount limit from NBFCs increased from 1 Crore 50 Lakhs to 2Crore 50Lakhs:The limit of the Amount of Loan that can be obtained from NBFCs that was originally resolved and approved to be Rs. 1 Crore 50 Lakhs was to be increased to 2 Crore 50 Lakhs and the same was approved....13-02-2017
Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016
Fredun Pharmaceuticals Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.28-01-2017
Board Meeting Intimation for Results
Fredun Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 13, 2017, to consider, approve and to take on records the Un-audited quarterly and nine monthly Financial Results for December 31, 2016.27-01-2017
Shareholding for the Period Ended December 31, 2016
Fredun Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click here23-01-2017